Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma

Table 1 Baseline characteristics of the 65 patients who underwent radiotherapy for unresectable hepatocellular carcinoma

Characteristics	Number of patients (%)
Age (yr)	60 (42-83)1
< 60/≥ 60	35 (53.8)/30 (46.2)
Gender (Male/Female)	56 (86.2)/9 (13.8)
Underlying liver disease (viral/alcohol)	52 (80.0)/13 (20.0)
Liver cirrhosis	50 (76.9)
Ascites	24 (36.9)
Child-Pugh class (A/B)	43 (66.2)/22 (33.8)
Albumin (g/dL)2	3.4 ± 0.5
Bilirubin (mg/dL)2	1.2 ± 0.9
Alkaline phosphatase (IU/L)2	151.8 ± 79.3
Platelet (103/mL)2	156.3 ± 66.2
Prothrombin time (INR)2	1.2 ± 0.2
Sodium (mEq/L)2	137.7 ± 3.7
Creatinine (mg/dL)2	1.0 ± 0.9
Tumor size (cm)2	10.8 ± 4.7
< 10/≥ 10	34 (52.3)/31 (47.7)
Tumor type (SN/MN/massive)	3 (4.6)/24 (36.9)/38 (58.5)
Portal vein thrombosis	45 (69.2)
UICC stage (III/IV-A)	12 (18.5)/53 (81.5)
α-fetoprotein (IU/mL)2	17 454 ± 66 005
> 400/ ≤ 400	28 (43.1)/37 (56.9)
Radiotherapy aim (primary/salvage)	40 (61.5)/25 (38.5)

¹Median (range);

²mean ± SD; INR: International normalized ratio; SN: Single nodular; MN: Multinodular.